December 12, 2024 11:22 AM EST

Handful of 'unsupported' drug price increases added $800M to US costs, ICER claims

Zachary Brennan

Senior Editor

The Institute for Clinical and Economic Review on Thursday released a new report arguing that US healthcare costs rose by more than $800 million from …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Handful of 'unsupported' drug price increases added $800M to US costs, ICER claims

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future

Lonza looks to depart capsule and health ingredients as it undergoes restructure

Padlock shareholders sue Bristol Myers over milestone dispute after 2016 acquisition

Keros halts parts of Phase 2 PAH trial due to safety, stock tanks 70%

Elevation to pay up to $368M in ADC deal; Bavarian Nordic closes San Diego site

The key to faster, more impactful research? Put patients in the driver’s seat

Hand­ful of 'un­sup­port­ed' drug price in­creas­es added $800M to US costs, ICER claims

Zachary Brennan

Senior Editor

Sign up to read this article for free.

In­side Iso­mor­phic Labs: Demis Has­s­abis’ lab-free vi­sion for biotech’s AI fu­ture

Lon­za looks to de­part cap­sule and health in­gre­di­ents as it un­der­goes re­struc­ture

Pad­lock share­hold­ers sue Bris­tol My­ers over mile­stone dis­pute af­ter 2016 ac­qui­si­tion

Keros halts parts of Phase 2 PAH tri­al due to safe­ty, stock tanks 70%

El­e­va­tion to pay up to $368M in ADC deal; Bavar­i­an Nordic clos­es San Diego site

The key to faster, more im­pact­ful re­search? Put pa­tients in the dri­ver’s seat

Handful of 'unsupported' drug price increases added $800M to US costs, ICER claims

Inside Isomorphic Labs: Demis Hassabis’ lab-free vision for biotech’s AI future

Lonza looks to depart capsule and health ingredients as it undergoes restructure

Padlock shareholders sue Bristol Myers over milestone dispute after 2016 acquisition

Keros halts parts of Phase 2 PAH trial due to safety, stock tanks 70%

Elevation to pay up to $368M in ADC deal; Bavarian Nordic closes San Diego site

The key to faster, more impactful research? Put patients in the driver’s seat